Optometry

Latest News


CME Content


A new device for at-home monitoring of age-related macular degeneration is a promising tool for early detection of choroidal neovascularization.

Twice-daily dosing of bepostastine besilate ophthalmic solution 1.5% was found to be safe, with minimal adverse events, in a randomized, double-masked, 6-week safety study including two groups of healthy pediatric patients.

An interactive computer-based surgical teaching program is being developed as a training tool to provide users with the cognitive aspects of learning that are fundamental for developing expertise.

The incidence of diabetes, which had been increasing by leaps and bounds along with complications of the disease, has been showing signs of stabilizing and decreasing as the result of intensive management of the disease.

A dermatologic treatment for patients who have rosacea and other skin conditions increasingly will find use as an ophthalmologic treatment for patients who have dry eye as a result of meibomian gland dysfunction and blepharitis.

A handheld tonometer that measures IOP through the eyelid and over the sclera is proving to be helpful for ophthalmologists faced with patients who are apprehensive about seeing an instrument approaching their eyesor who have a corneal abnormality.

The Video Journal of Cataract and Refractive Surgery celebrates its 25th anniversary with the opening of a high-definition Web site serving viewers in more than 150 countries.

Non-infectious uveitis involving the posterior segment is a leading cause of vision loss and long-term disability in the developed world and accounts for 10% to 20% of cases of legal blindness, particularly in younger individuals.

Despite a challenging economy and diminished endowment funds, ophthalmology departments around the country continue to grow and thrive with new ideas, significant discoveries, and stronger faculties as they train the next generation of caregivers, researchers and educators.

FDA OKs ophthalmic gel

The recent FDA approval of ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis brings to U.S. ophthalmologists an important advance in topical antiviral therapy for a condition that is the leading infectious cause of corneal blindness in the United States.

The FDA has granted 501(k) marketing clearance for a new digital fundus camera that combines mydriatic and non-mydriatic functions in a single device that may open the doors for the general ophthalmologist to monitor and treat some retinal diseases.